Pacira | PCRX - Current Liabilities


Pacira reported $107.08M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Assertio Holdings USD 166.78M 34.25M Sep/2025
Astellas Pharma JPY 1.32T 873M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Cara Therapeutics USD 10.68M 9.48M Jun/2025
Coherus Biosciences USD 372.3M 108.67M Sep/2025
Heron Therapeutics USD 89.71M 168.89M Sep/2025
Ironwood Pharmaceuticals USD 242.5M 9.98M Sep/2025
J&J USD 54.13B 3.26B Dec/2025
Ligand Pharmaceuticals USD 30.54M 34.2M Sep/2025
Nektar Therapeutics USD 66.34M 5.05M Sep/2025
Novo Nordisk DKK 215.66B 18.7B Dec/2025
Omeros USD 85.5M 2.28M Jun/2025
Pacira USD 107.08M 206.09M Sep/2025
Perrigo USD 1.15B 19.2M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Supernus Pharmaceuticals USD 330.63M 44.27M Sep/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025
Xoma USD 28.3M 6.81M Sep/2025
Zoetis USD 2.24B 428M Dec/2025